SurModics, Inc. ( SRDX) F1Q 2011 (Qtr End December 31, 2010) Earnings Call January 26, 2011 5:00 p.m. ET Management Phil Ankeny - SVP, CFO Gary Maharaj - CEO Analysts Ross Taylor - C.L. King & Associates Ernie Andberg - Feltl & Company Suraj Kalia - Rodman & Renshaw Beth Lilly - Gabelli Funds Daniel Owczarski - Avondale Partners Presentation Operator Good day, ladies and gentlemen, thank you for standing by. Welcome to the SurModics First Quarter 2011 Earnings Conference Call.
Previous Statements by SRDX
» SurModics CEO Discusses F4Q2010 Results - Earnings Call Transcript
» SurModics, Inc., F3Q10 (Qtr End 06/30/2010) Earnings Call Transcript
» SurModics, Inc. F2Q10 (Qtr End 03/31/10) Earnings Call Transcript
» SurModics, Inc. F1Q10 (Qtr End 12/31/09) Earnings Call Transcript
I will remind you that some of the statements made during this call may be considered forward-looking. The 10-K for fiscal year 2010 identifies certain factors that could cause the company's actual results to differ materially from those projected in any forward-looking statements made during this call. The company does not undertake any duty to update any forward-looking statements as a result of new information or future events or developments.Joining me on the call today is Gary Maharaj, our new Chief Executive Officer. As you know, Gary officially took the helm as CEO on December 27, 2010. He comes to us with 23 years experience in the medical device industry, most recently as CEO of Arizant, Inc. During his tenure at Arizant, he helped to refocus and refine its core business which ultimately resulted in improved operating and financial results. In fact, under Gary's leadership, Arizant nearly doubled annual revenues to over $200 million in less than five years. Additionally, Gary brings a strong background in R&D leadership to SurModics from his earlier years as the head of R&D at Arizant and in various management and research positions for the orthopedic implant and rehabilitation divisions of Smith & Nephew. As you listen to Gary's comments today, I believe the parallel between his accomplishments over his career and the opportunities here at SurModics will be quite evident. We are thrilled to have Gary onboard at SurModics and are excited to be able to leverage his expertise and leadership. On today's call Gary will discuss his reasons for joining SurModics and provide his initial observations and a broad overview of his outlook for the company. Afterwards I will highlight financial results and key achievements for the quarter. I will also comment on our financial outlook for fiscal 2011. And finally we will open the call to take your questions.
With that, let me turn the call over to Gary.Gary Maharaj Thank you, Phil. It's my pleasure to join all today for my first earnings conference call with SurModics. There are two things that I want to talk about today, first, why am I here? And second, I'll provide a high-level perspective of SurModics based on my initial observation. So let's talk about why I'm here. When I first became aware of the opportunity to become the CEO at SurModics, I immediately became excited at the prospect of leading the company for several compelling reasons. I believe that the ability to improve a medical device by surface modification is an important and ever-growing need in healthcare and that SurModics has the leadership position in this technology. Furthermore, I believe that a company with a competitive edge in cost-effective and clinically-relevant surface modification can have a major positive impact in healthcare. Finally, working with high-impact medical technology, seeing them help patients and in the process becoming commercially successful is personally important and rewarding to me. After further diligence and discussions with the board and management, my interest grew because I felt a fit with the team and their keen interest in improving the financial and competitive strength of the company. Bottom line, I saw an opportunity to build upon SurModics' leadership position, its broad technology platform, and to work with its talented employees, all with the goal of having a positive impact in patient outcomes and creating value for our shareholders and customers both current and future. Now it's been just over four weeks since I joined SurModics, and while I'm still getting acclimated, I've learned a great deal already from my interactions with employees and customers. My first order of business as CEO was to begin establishing trust and confidence with our employees, especially given the changes in the company during the past year.
've been impressed by not just the strength and quality of our employees, but their tenacity and desire to create a better future. I believe that our employees are proud of the work they do and are loyal to this organization. Importantly, they share my sense of urgency in restoring the 30-plus-year legacy of SurModics and returning our business to profitable growth. I'm enjoying working closely with them as we draw [ph] the future.Read the rest of this transcript for free on seekingalpha.com